DATA-DRIVEN BIOMEDICAL SUPPLY CHAINS: ENHANCING ACCESSIBILITY AND OUTCOMES FOR GLOBAL FAMILIES

Innovations in biomedical sciences have introduced life-saving technologies and therapies, but their global impact largely depends on efficient and accessible supply chains. This research examines how data-driven supply chain strategies can bridge the gap between biomedical innovation and global family health. Leveraging tools such as big data analytics, AI-driven demand forecasting, and real-time tracking systems, biomedical supply chains can enhance visibility, reduce lead times, and improve last-mile delivery, particularly in underserved regions. The study analyzes successful implementations in vaccine distribution, pharmaceutical logistics, and cold chain management across various countries. Furthermore, it highlights the role of interoperable data platforms and predictive analytics in anticipating disruptions and ensuring continuity. The research concludes by proposing a scalable, data-centric supply chain model that supports the equitable distribution of biomedical innovations to improve family health outcomes globally.